Catalyst Communications Company Profile

15:09 EDT 18th September 2018 | BioPortfolio

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. In a constantly evolving world, change is not only inevitable - it's desirable.
New products, services, resellers, partners, staff, customers. Successfully managing these transformations to differentiate yourself from the competition will make a positive impact on your bottom line. That's where Catalyst comes in.We construct individual PR campaigns that recognise your unique vision. Researched, designed and delivered with ingenuity and flair. Executed at speed with passion and creativity. Inspired, focused, technology-related public relations. So you stay ahead of the pack.


Siena CourtThe Broadway
United Kingdom


Phone: 44 (0) 845 226 30 36
Fax: 44 (0) 845 226 31 36

News Articles [431 Associated News Articles listed on BioPortfolio]

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

A ruthenium-based catalyst with highly active, flat surfaces outperforms metal-based competitors

Scientists in Japan and India have developed a reusable, high-performance catalyst based on flat-shaped ruthenium nanoparticles (Ru-NP) for the production of valuable chemicals. Due to its demonstrate...

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

Catalyst Pharmaceuticals enrols first patient in MSK-002 trial

Catalyst Pharmaceuticals has enrolled the first patient in its MSK-002 trial, a Phase III clinical study evaluating the efficacy and...Read More... The post Catalyst Pharmaceuticals enrols first patie...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalyst Biosciences, Inc. - CBIO

NEW YORK, June 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ("Catalyst" or the "Company") (NASDAQ: CBIO). Such investors are ...

Near-infrared photoactivatable oxygenation catalysts of amyloid peptide

(Japan Science and Technology Agency) A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-&...

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Heather LandiSalt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds d...

Drugs and Medications [0 Results]


PubMed Articles [461 Associated PubMed Articles listed on BioPortfolio]

Silicon carbide foam supported ZSM-5 composite catalyst for microwave-assisted pyrolysis of biomass.

Considering a series of issues facing the application of catalysts in large scale catalytic fast pyrolysis systems, a novel composite catalyst of ZSM-5 coatings on SiC foam supports was developed and ...

Microwave-assisted catalytic pyrolysis of moso bamboo for high syngas production.

Microwave-assisted pyrolysis of moso bamboo with the activated carbon-supported iron(III) ion catalyst was carried out with the aim of obtaining high quality and quantity syngas(H + CO). The effec...

Selective CO Evolution from Photoreduction of CO2 on a Metal-Carbide-Based Composite Catalyst.

A selective CO evolution from photoreduction of CO2 in wa-ter was achieved on a noble-metal-free, carbide-based compo-site catalyst, as demonstrated by a CO selectivity of 98.3% among all carbon-conta...

Excellent activity and selectivity of one-pot synthesized Cu-SSZ-13 catalyst in the selective catalytic oxidation of ammonia to nitrogen.

One-pot synthesized Cu-SSZ-13 catalyst treated with dilute HNO3 achieved superior activity and selectivity in the selective catalytic oxidation (SCO) of NH3 to nitrogen, in comparison with other zeoli...

Simplified Submission Requirements for Authors of JACS Communications.

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response

This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Healt...

Companies [528 Associated Companies listed on BioPortfolio]

Catalyst Communications

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. ...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Access Communications, LLC

Access Communications, LLC, (Access) is a premier strategic health care communications agency network comprised of 5 distinct organizations--Access Communications, Fusion Medical Communications, MedAc...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

More Information about "Catalyst Communications" on BioPortfolio

We have published hundreds of Catalyst Communications news stories on BioPortfolio along with dozens of Catalyst Communications Clinical Trials and PubMed Articles about Catalyst Communications for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Communications Companies in our database. You can also find out about relevant Catalyst Communications Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record